Tetanus Trials in Little Rock, United States
Conditions / Tetanus / Little Rock, United States
Research into Tetanus spans multiple therapeutic approaches and trial phases.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00109330 | A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine | COMPLETED | PHASE3 |
| NCT01311557 | Study of Adacel® Vaccine Administered to Persons 10 Years of Age | COMPLETED | PHASE4 |
| NCT00355121 | Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® | COMPLETED | PHASE2 |
| NCT00346073 | Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years | COMPLETED | PHASE3 |
| NCT00467519 | Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age | COMPLETED | PHASE3 |
| NCT01659996 | Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age | COMPLETED | PHASE4 |
| NCT00489970 | Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9 | COMPLETED | PHASE3 |
| NCT01439165 | Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose | COMPLETED | PHASE4 |
| NCT00802867 | Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ | COMPLETED | PHASE4 |
| NCT01346293 | Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age | COMPLETED | PHASE3 |